NCT06665425 - PK,PD and DDI of Epaminurad and C2406 in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

May 2, 2025

Study Completion Date

September 7, 2025

Conditions

Healthy Volunteers

Interventions

DRUG

Epaminurad 9 mg

Period 1: Epaminurad / Period 2: C2406 -\> Epaminurad + C2406

DRUG

C2406

Period 1: Epaminurad / Period 2: C2406 -\> Epaminurad + C2406

Trial Locations (1)

Seoul National University Hospital Clinical Trials Center, Seoul